Back | Next |
home / stock / nbio / nbio message board
Subject | By | Source | When |
---|---|---|---|
I have bids in down into the .03s. | gladeshawk | investorshub | 06/08/2023 3:09:09 PM |
Nice opportunity to add at these prices... Been | BlazingStocks | investorshub | 06/07/2023 7:37:34 PM |
$NBIO The abstract may be viewed on the | budfoxfun | investorshub | 06/07/2023 7:36:15 PM |
$NBIO - presented their Phase I therapeutic antibody | BlazingStocks | investorshub | 06/07/2023 6:34:36 PM |
.042's thinning here! | budfoxfun | investorshub | 06/07/2023 4:55:25 PM |
$NBIO trading about half of its 10-day average | BlazingStocks | investorshub | 06/07/2023 4:35:54 PM |
Absolutely... Phase II could be really soon based | BlazingStocks | investorshub | 06/07/2023 3:00:11 PM |
Sounds like the data looks really good... I'm | BlazingStocks | investorshub | 06/07/2023 2:59:12 PM |
Under .05 a steal here! | budfoxfun | investorshub | 06/07/2023 2:51:13 PM |
Agree, way undervalued at these levels. | budfoxfun | investorshub | 06/07/2023 1:18:25 PM |
Im feeling phase II is right around the corner | pumpnass | investorshub | 06/07/2023 1:00:26 PM |
Great to hear: The presentation displayed our Phase | budfoxfun | investorshub | 06/07/2023 12:21:55 PM |
Love the News this morning... Looking forward to | BlazingStocks | investorshub | 06/07/2023 12:15:52 PM |
$NBIO News June 07, 2023 Nascent Biotech Phase I | BlazingStocks | investorshub | 06/07/2023 12:11:34 PM |
$NBIO Premarket News! Nascent Biotech Phase I Clinical | budfoxfun | investorshub | 06/07/2023 12:09:03 PM |
$NBIO loading up this week, thin to .05's! | budfoxfun | investorshub | 06/07/2023 11:59:12 AM |
$NBIO, worth a flyer at current PPS. | gladeshawk | investorshub | 06/05/2023 4:11:55 PM |
Who says this stock was abandoned? Smart people | pumpnass | investorshub | 05/24/2023 7:43:49 PM |
Why was this pump abandoned lol | RammageRaul | investorshub | 05/23/2023 8:36:09 PM |
$NBIO could see a gap up this week | jedijazz | investorshub | 04/18/2023 7:35:58 PM |
News, Short Squeeze, Breakout and More Instantly...
NORTH PALM BEACH, FL / ACCESSWIRE / April 16, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, announces that it is embarking on a fresh manufacturin...
NORTH PALM BEACH, FL / ACCESSWIRE / March 19, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, and HypoSpray Pharma ("HypoSpray ® "), a clinical...
NORTH PALM BEACH, FL and NEW YORK, NY / ACCESSWIRE / February 6, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent"), a clinical-stage biotechnology company pioneering the development of monoclonal antibodies for the treatment of various cancers and viral infections, announc...